FFCP PHASE1:Mm9::chr6:115881982..115881996,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=212541|HGNC=|MCL_coexpression_id=16|UniProt=P15409|association_with_transcript=37bp_to_ENSMUST00000032471,NM_145383,uc009djk.1_5end|description=CAGE_peak_5_at_Rho_5end|id=chr6:115881982..115881996,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000970!7.03e-35!9;UBERON:0000019!7.03e-35!9;UBERON:0000047!7.03e-35!9;UBERON:0004088!7.03e-35!9;UBERON:0002104!7.03e-35!9;UBERON:0001456!7.03e-35!9;UBERON:0003072!7.03e-35!9;UBERON:0003071!7.03e-35!9;UBERON:0004128!7.03e-35!9;UBERON:0001444!1.22e-28!11;UBERON:0000020!2.69e-26!12;UBERON:0001032!2.69e-26!12;UBERON:0004456!2.69e-26!12;UBERON:0005085!2.59e-24!13|ontology_enrichment_uberon_v019_2=UBERON:0000970,1.98e-20,9;UBERON:0000019,1.98e-20,9;UBERON:0000047,1.98e-20,9;UBERON:0010312,1.98e-20,9;UBERON:0004088,1.98e-20,9;UBERON:0002104,1.98e-20,9;UBERON:0001456,1.98e-20,9;UBERON:0003072,1.98e-20,9;UBERON:0004128,1.98e-20,9;UBERON:0003071,1.98e-20,9;UBERON:0001444,5.67e-17,11;UBERON:0000020,1.13e-15,12;UBERON:0001032,1.13e-15,12;UBERON:0004456,1.13e-15,12;UBERON:0000033,1.42e-14,13;UBERON:0005085,1.42e-14,13|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.452167921657868,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.62811609134543,0,0,0,0,0.0680364991513279,0.12811372028485,0.468508622798644,18.3679393224701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.299033092087958,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p5@Rho}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:212541 | |||
|HGNC= | |||
|MCL_coexpression_id=16 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:P15409 | |||
|association_with_transcript=37bp_to_ENSMUST00000032471,NM_145383,uc009djk.1_5end | |||
|cluster_id=chr6:115881982..115881996,+ | |||
|description=CAGE_peak_5_at_Rho_5end | |||
|id=chr6:115881982..115881996,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000970!7.03e-35!9;UBERON:0000019!7.03e-35!9;UBERON:0000047!7.03e-35!9;UBERON:0004088!7.03e-35!9;UBERON:0002104!7.03e-35!9;UBERON:0001456!7.03e-35!9;UBERON:0003072!7.03e-35!9;UBERON:0003071!7.03e-35!9;UBERON:0004128!7.03e-35!9;UBERON:0001444!1.22e-28!11;UBERON:0000020!2.69e-26!12;UBERON:0001032!2.69e-26!12;UBERON:0004456!2.69e-26!12;UBERON:0005085!2.59e-24!13 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000970,1.98e-20,9;UBERON:0000019,1.98e-20,9;UBERON:0000047,1.98e-20,9;UBERON:0010312,1.98e-20,9;UBERON:0004088,1.98e-20,9;UBERON:0002104,1.98e-20,9;UBERON:0001456,1.98e-20,9;UBERON:0003072,1.98e-20,9;UBERON:0004128,1.98e-20,9;UBERON:0003071,1.98e-20,9;UBERON:0001444,5.67e-17,11;UBERON:0000020,1.13e-15,12;UBERON:0001032,1.13e-15,12;UBERON:0004456,1.13e-15,12;UBERON:0000033,1.42e-14,13;UBERON:0005085,1.42e-14,13 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.452167921657868,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.62811609134543,0,0,0,0,0.0680364991513279,0.12811372028485,0.468508622798644,18.3679393224701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.299033092087958,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p5@Rho | |||
}} |
Revision as of 23:00, 4 August 2015
Short description: | p5@Rho |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_5_at_Rho_5end |
Coexpression cluster: | MCL_coexpression_mm9:16 |
Association with transcript: | 37bp_to_ENSMUST00000032471, NM_145383, uc009djk.1_5end |
EntrezGene: | 212541 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
eye | 1.98e-20 | 9 |
camera-type eye | 1.98e-20 | 9 |
simple eye | 1.98e-20 | 9 |
immature eye | 1.98e-20 | 9 |
ocular region | 1.98e-20 | 9 |
visual system | 1.98e-20 | 9 |
face | 1.98e-20 | 9 |
optic cup | 1.98e-20 | 9 |
optic vesicle | 1.98e-20 | 9 |
eye primordium | 1.98e-20 | 9 |
subdivision of head | 5.67e-17 | 11 |
sense organ | 1.13e-15 | 12 |
sensory system | 1.13e-15 | 12 |
entire sense organ system | 1.13e-15 | 12 |
head | 1.42e-14 | 13 |
ectodermal placode | 1.42e-14 | 13 |